By Kevin E. Noonan — On January 6, 2020, a bi-partisan coalition of Senators, including Senator Collins (R-ME), Doug Jones (D-AL), Martha McSally (R-AZ), and Bob Menendez (D-NJ), introduced the “Ending the Diagnostic Odyssey Act of 2019” to permit states to use Medicaid funding for whole genome sequencing (WGS) analysis in children having certain rate diseases. The bill is a counterpart of H.R. 4144, introduced by Rep. Scott Peters (CA-52), joined by Rep. Shimkus and Mr. Vargas, on August 2, 2019. The stated purpose of the bill is “[t]o enable States to better provide access to whole genome sequencing clinical…
View the original article here: The "Ending the Diagnostic Odyssey Act of 2019"
The article was originally posted on Patent Docs.
Each article is copyrighted to their original authors. We do not own any rights to the news or the images used. Whilst every care is taken to ensure that the news posts published are accurate, we cannot guarantee the authenticity of the news article on every occasion. There’s no copyright infringement intended. The news is for informational purposes only and does not provide legal advice.